Afficher la couverture 'Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child–Pugh B cirrhosis | Blanc, Jean-Frédéric' en grand format
/5

0 avis

Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child–Pugh B cirrhosis

Archive ouverte

Blanc, Jean-Frédéric | Khemissa, Faiza | Bronowicki, Jean-Pierre | Monterymard, Carole | Perarnau, Jean-Marc | Bourgeois, Vincent | Obled, Stéphane | Abdelghani, Meher Ben | Mabile-Archambeaud, Isabelle | Faroux, Roger | Seitz, Jean-François | Locher, Christophe | Senellart, Hélène | Villing, Anne-Laure | Audemar, Franck | Costentin, Charlotte | Deplanque, Gaël | Manfredi, Sylvain | Edeline, Julien | Boucher, Evelyne | Talarmin, Marie | Le Sourd, Samuel | Vergniol, Julien | Gagnaire, Alice | Bedenne, Laurent | Jouve, Jean-Louis | Hillon, Patrick | Lepage, Côme | Minello, Anne | Barraud, Hélène | Lecomte, Thierry | Barbieux, Jean-Pierre | Wolff, Patrice | Phoutthasang, Valérie | Belletier, Christine | Archambeaud, Isabelle | Budnik, Tamara Matysiak | Schnee, Matthieu | Duluc, Muriel | Monnereau, Emmanuelle Norguet | Bennouna, Jaafar | Hiret, Sandrine | Gatineau, Michel | Ramdani, Mohamed | Le Bricquir, Yann | Ganne-Carrie, Nathalie | Bourcier, Valérie | Pilette, Christophe | Dauvois, Barbara | Baconnier, Mathieu | Michel, Pierre | Thevenet, Philippe | Cosme-Gassmann, Hélène | Habersetzer, François | Coltescu, Camélia | Pauwels, Mathieu | Brissonneau, Sophie Nahon | Egreteau, Joëlle | Desrame, Jérôme | Auby, Dominique | Texereau, Patrick | Etienne, Pierre-Luc | Dourthe, Louis-Marie | Tazi, Youssef

Edité par CCSD ; Springer Internat. Publ -

International audience

Suggestions

Du même auteur

Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer

Archive ouverte | Boisteau, Emeric | CCSD

International audience. Introduction Predictive markers of LV5FU2 maintenance benefit after first-line induction with FOLFIRINOX in patients with metastatic pancreatic cancer are necessary to select patients who wil...

Difficulties for providing evidence in hepatocellular carcinoma with Child-Pugh B liver function

Archive ouverte | Edeline, Julien | CCSD

International audience

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial

Archive ouverte | Conroy, Thierry | CCSD

Chargement des enrichissements...